Oxytocin and social cognition in affective and psychotic disorders
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Impairments in social cognition are now recognized as core illness features in psychotic and affective disorders. Despite the significant disability caused by social cognitive abnormalities, treatments for this symptom dimension are lacking. Here, we describe the evidence demonstrating abnormalities in social cognition in schizophrenia, major depressive disorder, and bipolar disorder, as well as the neurobiology of social cognition including the role of oxytocin. We then review clinical trials of oxytocin administration in psychotic and affective disorders and the impact of this agent on social cognition. To date, several studies have demonstrated that oxytocin may improve social cognition in schizophrenia; too few studies have been conducted in affective disorders to determine the effect of oxytocin on social cognition in these disorders. Future work is needed to clarify which aspects of social cognition may be improved with oxytocin treatment in psychotic and affective disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding and sharing intentions: The origins of cultural cognition
Tomasello, M., Carpenter, M., Call, J., Behne, T., & Moll, H. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000129 · Cited by 4,882
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
The relation of empathy to prosocial and related behaviors
Eisenberg, N., & Miller, P. A. (1987) · Psychological Bulletin · doi:10.1037/0033-2909.101.1.91 · Cited by 2,672 · cited 2×
“Social cognition may be defined as the “psychological processes that enable individuals to take advantage of being part of a social group” (Frith, 2008), and it is crucial for maintaining social relationships (Eisenberg and Miller, 1987).”
BackgroundHappé, F. G. E. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172093 · Cited by 2,352 · cited 1×
“One study found that although BD patients performed worse than controls on a naturalistic ToM task (Happé, 1994), there were no differences between patients with and without a history of psychosis (Lahera et al.”
BackgroundHeinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · cited 1×
“While not a study of a formal psychotherapy, a recent study examining the combination of oxytocin with social support found evidence that this combination exerted a more beneficial effect on cortisol responses to social stress than either intervention administered individually (Heinrichs et al., 2003).”
BackgroundFett, A.-K. J., Viechtbauer, W., Dominguez, M.-D.-G., Penn, D. L., van Os, J., & Krabbendam, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.001 · Cited by 1,833
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 10×
“Because of its anxiolytic, prosocial, and social cognitiveenhancing effects (Bakermans-Kranenburg and van, 2013; Bos et al., 2012; Gumley et al., 2014; Macdonald and Macdonald, 2010; Meyer-Lindenberg et al., 2011; Zink and Meyer-Lindenberg, 2012), oxytocin has been suggested as a promising novel treatment for patients…”
BackgroundInfluentialSocial effects of oxytocin in humans: context and person matter
Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.05.002 · Cited by 1,581
Corcoran, R., Mercer, G., & Frith, C. D. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00024-g · Cited by 1,340
Introducing MASC: A Movie for the Assessment of Social Cognition
Dziobek, I., Fleck, S., Kalbe, E., Rogers, K., Hassenstab, J., Brand, M., Kessler, J., Woike, J. K., Wolf, O. T., & Convit, A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0107-0 · Cited by 926 · cited 1×
“Two studies have tested patients with MDD using the Movie for the Assessment of Social Cognition (MASC; Dziobek et al., 2006).”
Method
Cited by
Social brain, social dysfunction and social withdrawal
Porcelli, S., Van Der Wee, N., van der Werff, S., Aghajani, M., Glennon, J. C., van Heukelum, S., Mogavero, F., Lobo, A., Olivera, F. J., Lobo, E., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.012 · Cited by 391
Cotter, J., Granger, K., Backx, R., Hobbs, M., Looi, C. Y., & Barnett, J. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.014 · Cited by 369
Quintana, D. S., Alvares, G. A., Hickie, I. B., & Guastella, A. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.011 · Cited by 149
Ma, Y., Shamay-Tsoory, S., Han, S., & Zink, C. F. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.10.009 · Cited by 131
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Metadata
- Authors
- Mercedes Perez-Rodriguez, M., Mahon, K., Russo, M., Ungar, A. K., & Burdick, K. E.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 25
- Issue
- 2
- Pages
- 265-282
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2078217719
- Cited by
- 52
- References
- 75
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxytocin and social cognition in affective and psychotic disorders. https://app.cochat.ai/papers/10.1016/j.euroneuro.2014.07.012
- The paper
- Mercedes Perez-Rodriguez, M., Mahon, K., Russo, M., Ungar, A. K., & Burdick, K. E. (2015). Oxytocin and social cognition in affective and psychotic disorders. European Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2014.07.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.